The PROMISE Consortium is pioneering research in the early stages of Crohn’s disease before clinical symptoms emerge. It stands as the first consortium to comprehensively explore the predictive and preventive aspects through omics- and microbiome-related, immunological, and environmental factors.
Made possible by
Earlier this year, the PROMISE Consortium convened an international, multidisciplinary effort focused on a fundamental shift in IBD research: moving prevention upstream. That effort has now culminated in a newly published white paper in Gastroenterology. The paper outlines a research roadmap to advance early identification, risk stratification, and prevention strategies for inflammatory bowel disease, integrating insights…
Keep readingThis month’s specialty Genetics report highlighted the work that the PROMISE Consortium is doing to get ahead of Crohn’s Disease. Give this a read for an update on our work, and a quick history lesson on the rich legacy of research in Crohn’s Disease at the Mount Sinai Medical Center. https://reports.mountsinai.org/article/genetics2025-getting-ahead-of-crohns-disease
Keep readingWe are excited to host the Prediction and Prevention in Crohn’s Disease Workshop on April 30th and May 1st, 2025, at the Leon and Norma Hess Center for Science and Medicine at the Icahn School of Medicine at Mount Sinai in New York City. Our team believes that your research and work in rheumatology can help to illuminate and enhance…
Keep readingContinuing the prediction and prevention goals of the PREDICTS, GEM, Nurses’ Health Study, MECONIUM Study and Road To Prevention Study cohorts, our team is excited to announce our collaboration through the PROMISE Consortium. This initiative will explore early risk factors of Crohn’s disease and focus on targets to develop new prevention strategies. Stay in touch…
Keep readingExcited to get some of the team together in person for the first time at Digestive Disease Week 2025, in beautiful Washington, DC. Be Gutsy!
Keep reading
PROMISE CONSORTIUM 